Behavioural management of antipsychotic-induced weight gain: a review

被引:36
|
作者
Werneke, U
Taylor, D
Sanders, TA
Wessely, S
机构
[1] Inst Psychiat, Ctr Econ Mental Hlth, London, England
[2] Maudsley Hosp & Inst Psychiat, Dept Pharm, London SE5 8AZ, England
[3] Kings Coll London, Dept Nutr & Dietet, London WC2R 2LS, England
[4] Kings Coll London, Sch Med & Dent, Acad Dept Psychol Med, London WC2R 2LS, England
关键词
weight gain; atypical antipsychotics; diet; exercise; review; randomized controlled trial;
D O I
10.1034/j.1600-0447.2003.00190.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Although psychiatrists are aware of weight gain induced by atypical antipsychotics, only few studies on behavioural interventions in this patient group are published. T his review aims to summarize the evidence on effectiveness of behavioural interventions for weight gain in the general population and in-patients treated with atypical antipsychotics. Method: Medline and Cochrane databases search for evidence on effectiveness of behavioural interventions. Results: In general, behavioural approaches including, diet, exercise and drug treatments may be effective. There were only 13 studies of behavioural interventions for patients taking antipsychotic medication. No study met the criteria for a RCT. Calorie restriction in a controlled ward environment, structured counselling combined with cognitive behavioural therapy and counselling on life style and provision of rewards may potentially lead to weight loss. Conclusion: Currently only limited, methodologically. awed, evidence is available that behavioural interventions in overweight patients treated with antipsychotics, although intuitively appealing, actually work.
引用
收藏
页码:252 / 259
页数:8
相关论文
共 50 条
  • [41] Is antipsychotic-induced weight gain related to sexual dysfunction?
    Rejas, J
    Bobes, J
    Garcia-Garcia, M
    Rico-Villademoros, F
    García-Portilla, MP
    Madrigal, M
    Hernández, G
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S282 - S283
  • [42] Plasma leptin and antipsychotic-induced body weight gain
    Monteleone, P
    Fabrazzo, M
    Maj, M
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 (09) : 1769 - 1769
  • [43] Plasma Leptin and Antipsychotic-Induced Body Weight Gain
    Palmiero Monteleone
    Michele Fabrazzo
    Mario Maj
    Neuropsychopharmacology, 2005, 30 : 1769 - 1769
  • [46] Antipsychotic-induced weight gain: Is the weight over? New guidelines needed
    de Boer, Nini
    Cahn, Wiepke
    ACTA PSYCHIATRICA SCANDINAVICA, 2022, 146 (03) : 185 - 189
  • [47] Meralgia paresthetica: another complication of antipsychotic-induced weight gain
    Chlebowski, S.
    Bashyal, S.
    Schwartz, T. L.
    OBESITY REVIEWS, 2009, 10 (06) : 700 - 702
  • [48] Association of orexin receptor polymorphisms with antipsychotic-induced weight gain
    Tiwari, Arun K.
    Brandl, Eva J.
    Zai, Clement C.
    Goncalves, Vanessa F.
    Chowdhury, Nabilah I.
    Freeman, Natalie
    Lieberman, Jeffrey A.
    Meltzer, Herbert Y.
    Kennedy, James L.
    Mueller, Daniel J.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2016, 17 (03): : 221 - 229
  • [49] Antipsychotic-Induced Weight Gain and Clinical Improvement: A Psychiatric Paradox
    Garcia-Rizo, Clemente
    FRONTIERS IN PSYCHIATRY, 2020, 11
  • [50] Contingency Management for the Treatment of Antipsychotic-Induced Weight Gain: A Randomized Controlled Pilot Study
    Ratliff, Joseph C.
    Palmese, Laura B.
    Tonizzo, K. Melek
    Chwastiak, Lydia
    Tek, Cenk
    OBESITY FACTS, 2012, 5 (06) : 919 - 927